STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $104,000 | -1.9% | 6,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $106,000 | -87.6% | 6,800 | -91.4% | 0.00% | -83.3% |
| Q3 2016 | $852,000 | -27.7% | 78,679 | -54.8% | 0.01% | -25.0% |
| Q2 2016 | $1,179,000 | +45.2% | 174,179 | 0.0% | 0.01% | +60.0% |
| Q1 2016 | $812,000 | -19.1% | 174,179 | +9.4% | 0.01% | -16.7% |
| Q4 2015 | $1,004,000 | +198.8% | 159,179 | +318.9% | 0.01% | +200.0% |
| Q3 2015 | $336,000 | – | 38,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |